Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. (Record no. 15269718)

MARC details
000 -LEADER
fixed length control field 01554 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514212116.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200505s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1526-8209
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3816/cbc.2004.n.040
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Harbeck, Nadia
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20050519
245 00 - TITLE STATEMENT
Title Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical breast cancer
Date of publication, distribution, etc. Dec 2004
300 ## - PHYSICAL DESCRIPTION
Extent 348-52 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme-Linked Immunosorbent Assay
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoadjuvant Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Plasminogen Activator Inhibitor 1
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Urokinase-Type Plasminogen Activator
General subdivision analysis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kates, Roanld E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schmitt, Manfred
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gauger, Katja
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kiechle, Marion
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Janicke, Fritz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomassen, Christoph
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Look, Maxime P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Foekens, John A
773 0# - HOST ITEM ENTRY
Title Clinical breast cancer
Related parts vol. 5
-- no. 5
-- p. 348-52
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3816/cbc.2004.n.040">https://doi.org/10.3816/cbc.2004.n.040</a>
Public note Available from publisher's website

No items available.